top of page

Biopharma Pulse: 4/17-4/21 Weekly Review

Updated: Apr 21, 2023



Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and categories on BPIQ.com compared to XBI. Want stock picks and ideas? Sign up for Amp Bio Pro! Learn more here.





Table 1. BPIQ company weekly moves and YTD moves

Category

Weekly Move 4/17-4/21

YTD Median Move

BPIQ Index*

16.22%

-3.07%

CAR-T Companies

4.92%

-13.22%

Gene Editing Companies

2.08%

-11.68%

Alzheimer's Disease Companies

3.08%

-5.58%

NASH & Liver Disease Companies

4.24%

10.96%

XBI

5.04%

-1.05%

*All smid-cap biopharma companies between $50M and $12.5B



See the biggest moves from last week below:


 


 


Biggest positive move this week

$BLU +104% - GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health.



Biggest negative move this week

$KNTE -47% - Dose Escalation Data for Exarafenib as a Single Agent and in Combination with Binimetinib in BRAF-altered Cancers and NRAS Mutant Melanoma.



Major Weekly Moves and News



Highlights for next week

  • $SGEN PDUFA

  • AAN biomedical conference

  • $KTX Ph 3 data

  • $DNLI Ph 1b data

  • $IONS PDUFA

  • $BIIB PDUFA

  • $MCRB PDUFA


See our Big Movers post to learn about upcoming Q2 Movers, after subscribing. Learn more here.



0 comments

Comments


bottom of page